
Preventric is a commercial-stage digital health company redefining the way vascular diseases are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities. The company derives its revenue in the United States. Its BPro® wearable has been in 20+ clinical trials on 20,000 patients, cited in 70+ peer-reviewed science & medical journals, globally patented, and FDA-cleared for physician use and reimbursement.

Preventric is a commercial-stage digital health company redefining the way vascular diseases are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine learning capabilities. The company derives its revenue in the United States. Its BPro® wearable has been in 20+ clinical trials on 20,000 patients, cited in 70+ peer-reviewed science & medical journals, globally patented, and FDA-cleared for physician use and reimbursement.
Stage: Commercial-stage digital health company
Core product: BPro® wearable blood-pressure/vascular biosensing device
Clinical validation: Used in 20+ clinical trials on ~20,000 patients
Regulatory & IP: FDA-cleared for physician use and reimbursement; globally patented
Funding (reported): Total funding reported: $2,100,000 (last funding date 2020-08-27)
Website status: preventric.com currently resolves to a domain-for-sale landing page
Clinical diagnosis and monitoring of vascular diseases (blood-pressure and vascular assessment) via wearable biosensing
Digital Health
2100000.00
Last funding date reported 2020-08-27 (total funding reported $2,100,000)